上海锦天城（杭州）律师事务所 关于宁波三星医疗电气股份有限公司 差异化分红事项的 法律意见书 地址：浙江省杭州市上城区富春路 308 号华成国际发展大厦 12 楼 电话：0571-89838088 传真：0571-89838099 邮编：310000 上海锦天城（杭州）律师事务所 法律意见书 上海锦天城（杭州）律师事务所 关于宁波三星医疗电气股份有限公司 差异化分红事项的 法律意见书 致：宁波三星医疗电气股份有限公司 上海锦天城（杭州）律师事务所（以下简称"本所"）接受宁波三星医疗电 气股份有限公司（以下简称"公司"）委托，根据《中华人民共和国公司法》（以 下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上 海证券交易所上市公司自律监管指引第 7 号——回购股份》等法律、法规、规章 和其他规范性文件以及《宁波三星医疗电气股份有限公司章程》（以下简称《公 司章程》）的有关规定，就公司 2025 年半年度利润分配所涉及的差异化分红（以 下简称"本次差异化分红"）相关事项出具本法律意见书。 为出具本法律意见书，本所及本所律师审查了公司提供的本次差异化分红的 相关文件，就有关事项向公司进 ...

证券代码：601567 证券简称：三星医疗 公告编号：临2025-080 宁波三星医疗电气股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2. 分派对象： 重要内容提示： 每股分配比例 A 股每股现金红利0.485元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/10/17 | － | 2025/10/20 | 2025/10/20 | 差异化分红送转： 是 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 9 月 8 日的2025年第二次临时股东会审议通过。 二、 分配方案 1. 发放年度：2025年半年度 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东 （回购专用证券账户中的股份除外）。 公司根据《上海证券交易所交易规则》 ...

Core Viewpoint - Samsung Medical's stock experienced a slight decline of 0.37% on September 29, with a trading volume of 576 million yuan, indicating a mixed market sentiment towards the company [1]. Financing Summary - On September 29, Samsung Medical had a financing buy-in amount of 56.18 million yuan, with a net financing purchase of 10.93 million yuan after repayments [1]. - The total financing and securities balance for Samsung Medical reached 377 million yuan, with the financing balance accounting for 1.09% of the circulating market value, indicating a high level compared to the past year [1]. - The company had a low short-selling balance of 2.02 million yuan, with a short-selling volume of 3,800 shares on the same day [1]. Business Performance - As of June 30, Samsung Medical reported a total of 29,000 shareholders, an increase of 76.91% from the previous period, while the average circulating shares per person decreased by 43.15% to 48,732 shares [2]. - For the first half of 2025, Samsung Medical achieved an operating revenue of 7.972 billion yuan, representing a year-on-year growth of 13.93%, and a net profit attributable to shareholders of 1.230 billion yuan, up 6.93% year-on-year [2]. Dividend Information - Since its A-share listing, Samsung Medical has distributed a total of 5.728 billion yuan in dividends, with 2.650 billion yuan distributed over the past three years [3]. Institutional Holdings - As of June 30, 2025, Hong Kong Central Clearing Limited was the fourth largest circulating shareholder of Samsung Medical, holding 47.9803 million shares, an increase of 3.9134 million shares from the previous period [3].

Group 1 - Multiple listed companies have recently announced pre-bid results for State Grid projects, indicating a trend of increasing participation in government contracts [1][2] - Zhejiang Wansheng Intelligent Technology Co., Ltd. is a candidate for a State Grid project with a pre-bid amount of approximately 67.98 million yuan, representing 7.25% of its audited revenue for 2024 [1] - Ningbo Sanxing Medical Electric Co., Ltd. and Hangzhou Haixing Electric Power Technology Co., Ltd. also reported significant pre-bid amounts, with total expected bids of approximately 193 million yuan and 128 million yuan respectively [1] Group 2 - The investment in China's power grid is experiencing rapid growth, with a reported investment of 291.1 billion yuan in the first half of 2025, a year-on-year increase of 14.6% [2] - Equipment investment within the grid construction has seen a substantial increase of 39.6% year-on-year, highlighting a focus on technological advancements [2] - The State Grid is prioritizing investments in areas such as ultra-high voltage projects, digital upgrades of distribution networks, and renewable energy integration [2] Group 3 - In the first half of 2025, the newly connected capacity of wind and solar energy in the State Grid's operational area reached 203 million kilowatts, a remarkable growth of 108.7% year-on-year [3] - The ongoing construction of ultra-high voltage direct current projects is facilitating the transmission of renewable energy from resource-rich western regions [3] - The outlook for future investments in the power grid remains optimistic, with expectations for continued growth driven by increasing clean energy demands [3]

Core Viewpoint - Samsung Medical (601567) announced a share reduction plan by its director and board secretary, Guo Su, due to personal financial needs [1] Summary by Relevant Sections - **Shareholding Information** - Guo Su holds 600,000 shares, representing 0.04% of the company's total share capital [1] - **Reduction Plan Details** - Guo Su plans to reduce her holdings by up to 150,000 shares, which is not more than 0.01% of the company's total share capital [1] - The total number of shares to be reduced will not exceed 25% of her current holdings [1]

证券代码：601567 证券简称：三星医疗 公告编号：临2025-079 | 股东名称 | 郭粟 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 | √否 | | | 直接持股 5%以上股东 | □是 | √否 | | | 董事、监事和高级管理人员 | √是 | □否 | | | 其他： | | | | 持股数量 | 600,000股 | | | | 持股比例 | 0.04% | | | 一、减持主体的基本情况 1 董监高持股的基本情况：截至本公告披露日，宁波三星医疗电气股份 有限公司（以下简称"公司"）董事、董事会秘书郭粟女士持有公司股 份 600,000 股，占公司总股本的 0.04%。 减持计划的主要内容：公司于近日收到董事、董事会秘书郭粟女士的 《关于集中竞价减持计划告知函》，郭粟女士因个人资金需求，计划自 本减持计划公告之日起 15 个交易日后的 3 个月内，以集中竞价交易方 式减持股份数量不超过 150,000 股，即不超过公司总股本的 0.01%。郭 粟女士拟减持股份总数不超过其本人所持股份总数的 25%。减持价格 根据减 ...

Group 1 - Samsung Medical announced that as of the disclosure date, its board member and secretary, Ms. Guo Su, holds 600,000 shares, accounting for 0.04% of the total share capital [1] - Ms. Guo plans to reduce her holdings by up to 150,000 shares, which is no more than 0.01% of the total share capital, due to personal financial needs [1] - The reduction will occur within three months after the announcement, with a maximum of 25% of her total holdings being sold [1] Group 2 - For the year 2024, Samsung Medical's revenue composition is as follows: manufacturing accounts for 76.16%, medical services for 22.31%, other businesses for 1.48%, and financial services for 0.04% [1] - As of the report, Samsung Medical has a market capitalization of 34.3 billion yuan [1]

Core Viewpoint - Samsung Medical (601567) announced that its director and board secretary, Ms. Guo Su, plans to reduce her holdings by a maximum of 150,000 shares, representing 0.01% of the company's total share capital, from October 24, 2025, to January 23, 2026 [1] Summary by Relevant Sections - **Shareholding Details** - Ms. Guo Su currently holds 600,000 shares, which is 0.04% of the company's total share capital, all obtained through equity incentives [1] - **Impact on Company** - The planned reduction will not have a significant impact on the company's governance structure or ongoing operations [1] - **Reduction Method and Pricing** - The share reduction will be executed through centralized bidding, with the selling price determined based on market conditions [1]

格隆汇9月24日丨三星医疗(601567.SH)公布，公司于近日收到董事、董事会秘书郭粟女士的《关于集中 竞价减持计划告知函》，郭粟女士因个人资金需求，计划自本减持计划公告之日起15个交易日后的3个 月内，以集中竞价交易方式减持股份数量不超过15万股，即不超过公司总股本的0.01%。郭粟女士拟减 持股份总数不超过其本人所持股份总数的25%。减持价格根据减持实施时的市场价格确定。 ...

Core Viewpoint - The Shanghai Composite Index is currently above the six-month moving average, with a slight decline of 1.04% and a total trading volume of 1.262 trillion yuan [1] Group 1: Market Performance - As of 10:29 AM today, the Shanghai Composite Index stands at 3788.76 points, indicating a trading volume of 12,621.13 million yuan [1] - There are 13 A-shares that have surpassed the six-month moving average today, with notable stocks including Air China Ocean, Guisheng Co., and Samsung Medical, showing divergence rates of 4.09%, 2.35%, and 1.79% respectively [1] Group 2: Individual Stock Analysis - The top three stocks with the highest divergence rates are: - Air China Ocean (Code: 833171) with a price increase of 4.78%, a turnover rate of 10.78%, a six-month moving average of 10.52 yuan, and a latest price of 10.95 yuan, resulting in a divergence rate of 4.09% [1] - Guisheng Co. (Code: 600992) with a price increase of 4.08%, a turnover rate of 5.15%, a six-month moving average of 14.45 yuan, and a latest price of 14.79 yuan, resulting in a divergence rate of 2.35% [1] - Samsung Medical (Code: 601567) with a price increase of 4.73%, a turnover rate of 2.47%, a six-month moving average of 23.27 yuan, and a latest price of 23.69 yuan, resulting in a divergence rate of 1.79% [1]